JAUNDICE DURING TREATMENT WITH AN ORAL CONTRACEPTIVE, LYNDIOL.
D000410:Alanine Transaminase; D000469:Alkaline Phosphatase / Q000097:blood*; D001219:Aspartate Aminotransferases; D001663:Bilirubin; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury; D003276:Contraceptives, Oral; D051263:D-Alanine Transaminase; D004338:Drug Combinations; D005260:Female; D006505:Hepatitis; D006801:Humans; D007565:Jaundice; D008111:Liver Function Tests; D008234:Lynestrenol; D008656:Mestranol; D010336:Pathology; D014116:Toxicology
D003276:Contraceptives, Oral; D004338:Drug Combinations; C002746:Noracycline; D008656:Mestranol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D051263:D-Alanine Transaminase; D000469:Alkaline Phosphatase; D008234:Lynestrenol; D001663:Bilirubin
ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOPSY; BLOOD ALKALINE PHOSPHATASE; HEPATITIS, TOXIC; LIVER FUNCTION TESTS; LYNESTRENOL; MESTRANOL; PATHOLOGY; TOXICOLOGIC REPORT